How Gsx genes shape the brain regions that control movement and attention
Roles of Gsx factors in basal ganglia development
This work looks at how changes in the GSX2 gene affect the developing brain cells that form the basal ganglia, which can cause movement, learning, and attention problems in children.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11253936 on NIH RePORTER |
What this research studies
If your child had a GSX2 change, this research uses a mouse model carrying the same human genetic variant to follow how brain progenitor cells form the basal ganglia during development. Researchers compare embryos with the variant to normal controls to look for missing or altered neuron types and overall brain structure changes. The team also ties findings to human patient reports and MRI results that showed severe basal ganglia loss in some children with GSX2 variants. Findings aim to link a specific genetic change to the brain differences that cause symptoms like dystonia, developmental delay, and attention problems.
Who could benefit from this research
Good fit: Children (or families) with rare GSX2 gene variants, early-onset movement disorders such as dystonia, severe developmental delay, or congenital basal ganglia abnormalities would be most relevant.
Not a fit: People with common ADHD without suspected genetic basal ganglia abnormalities or adult-onset attention problems are unlikely to get direct benefit from this specific genetic and developmental research.
Why it matters
Potential benefit: Better understanding of how GSX2 gene changes cause basal ganglia problems could improve genetic diagnosis and guide future therapies for related movement and developmental disorders.
How similar studies have performed: Previous mouse studies and a small number of human case reports have linked loss of GSX2 function to basal ganglia defects, but modeling the specific human missense variant in mice is a newer approach.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Campbell, Kenneth J — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Campbell, Kenneth J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.